Nanomedicine News

RSS

Study Shows Lung Mucus Prevents Drug Nanoparticles from Reaching their Target Destination

Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the extent to which such nanoparticles are able to move through the lungs' mucus. Here, the research evidence was contradictory.

25 Oct 2012

Chesapeake PERL Receives NCI Award to Develop Protein Nanoparticle for Lung Cancer Therapy

Chesapeake PERL has received a Small Business Innovation Research award from the National Cancer Institute to continue development of a protein nanoparticle linked to an antitumor agent as a potential lung cancer therapeutic. C-PERL collaborators in the laboratory of Dr. Leonard Rome, Professor of Biological Chemistry at UCLA have identified and characterized the vault particle, a unique nanoparticle structure ubiquitous in eukaryotes.

25 Oct 2012

First Place Poster Presentation Award for Alpha-Particle Nano-Generator Actinium-225 Drug

Actinium Pharmaceuticals, Inc., (API), a private biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced that the poster summarizing the results for Phase I study of Actimab-A, its antibody directed alpha emitter drug candidate, has won a first place poster presentation award at the 8th Annual Hematologic Malignancies 2012 Conference held in Houston, TX, from October 10-14.

25 Oct 2012

Merck Serono to Provide Strategic Support for Auxogyn's Early Embryo Viability Assessment Test

Merck Serono, a division of Merck, Darmstadt, Germany, and Auxogyn, Inc., a company focused on revolutionizing the field of reproductive health, today announced that they have entered into a strategic agreement focused on Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test. Under the terms of the agreement, Merck Serono will provide strategic, scientific and medical support in the development and commercialization of the Eeva™ Test.

20 Oct 2012

VNT Paclitaxel Nanocarrier-Based Drug Coated Balloon Technology Performs Well in In Vivo Tests

Vascular Nanotransfer Technologies (“VNT”), an emerging medical technology company, announced today that large animal model in vivo tests of its paclitaxel nanocarrier-based Drug Coated Balloon (“DCB”) achieved tissue levels comparable to devices with proven clinical efficacy.

20 Oct 2012

Multi-Functional, NIR Responsive Gold Nanorods for Targeted Delivery of Chemotherapy Drugs

Excitement around the potential for targeted nanoparticles (NPs) that can be controlled by stimulus outside of the body for cancer therapy has been growing over the past few years. More specifically, there has been considerable attention around near-infrared (NIR) light as an ideal method to stimulate nanoparticles from outside the body.

19 Oct 2012

Scientists Determine 3-D Structure of Transcription Initiation Complex

An team of Rutgers University scientists led by Richard H. Ebright and Eddy Arnold has determined the three-dimensional structure of the transcription initiation complex, the key intermediate in the process by which cells read out genetic information in DNA.

19 Oct 2012

INNI Appoints TAU to Lead Consortium on Nanomedicines for Personalized Theranostics

Tel Aviv University has been appointed by the Israel National Nanotechnology Initiative (INNI) to lead a consortium on "Nanomedicines for Personalized Theranostics," a combined system of diagnostics and therapeutic treatments. This consortium of 11 laboratories will be dedicated to developing nano-sized drug delivery systems for the detection and treatment of various diseases. Eight of the labs are TAU-led, with additional participation from Hebrew University Jerusalem, Bar-Ilan University and Ben Gurion University of the Negev.

19 Oct 2012

Novavax Announces Encouraging Clinical Trial Results for Nanoparticle-Based Pandemic Influenza Vaccine

Novavax, Inc. today reported positive top-line results from two Phase 1 clinical trials of its A/H5N1 avian influenza vaccine candidate administered alone or with either one of two undisclosed adjuvants.

18 Oct 2012

New Nanoparticle-Based Treatment Holds Potential for Traumatic Brain Injury

A potential new treatment for traumatic brain injury (TBI), which affects thousands of soldiers, auto accident victims, athletes and others each year, has shown promise in laboratory research, scientists are reporting.

18 Oct 2012

Nanomedicine News

Study Shows Lung Mucus Prevents Drug Nanoparticles from Reaching their Target Destination

Chesapeake PERL Receives NCI Award to Develop Protein Nanoparticle for Lung Cancer Therapy

First Place Poster Presentation Award for Alpha-Particle Nano-Generator Actinium-225 Drug

Merck Serono to Provide Strategic Support for Auxogyn's Early Embryo Viability Assessment Test

VNT Paclitaxel Nanocarrier-Based Drug Coated Balloon Technology Performs Well in In Vivo Tests

Multi-Functional, NIR Responsive Gold Nanorods for Targeted Delivery of Chemotherapy Drugs

Scientists Determine 3-D Structure of Transcription Initiation Complex

INNI Appoints TAU to Lead Consortium on Nanomedicines for Personalized Theranostics

Novavax Announces Encouraging Clinical Trial Results for Nanoparticle-Based Pandemic Influenza Vaccine

New Nanoparticle-Based Treatment Holds Potential for Traumatic Brain Injury

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting